BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37748956)

  • 1. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
    Wang G; Si Y; Liu J; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of
    Feng L; Yang S; Lin Y; Li J; Cao Z; Zheng Q; Wang H; Yang J
    Pediatr Radiol; 2024 May; 54(6):954-964. PubMed ID: 38613691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic parameters of pretreatment 2-[
    Li C; Dong Y; Pan Y; Han Y; Zhang J; Luan X; Liu J; Xu X; Guan Z; Wang G; Xu B
    Quant Imaging Med Surg; 2024 Jan; 14(1):604-617. PubMed ID: 38223061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
    Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
    Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.
    Kang SY; Rahim MK; Kim YI; Cheon GJ; Kang HJ; Shin HY; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Mol Imaging; 2017 Jun; 51(2):154-160. PubMed ID: 28559940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Histogram-Based Textural Analysis of
    Önner H; Coşkun N; Erol M; Eren Karanis Mİ
    Mol Imaging Radionucl Ther; 2022 Feb; 31(1):33-41. PubMed ID: 35114750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity in
    Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
    Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Overall Survival and Progression-Free Survival by the
    Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
    Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of pretreatment
    Sung AJ; Weiss BD; Sharp SE; Zhang B; Trout AT
    Pediatr Radiol; 2021 Jul; 51(8):1400-1405. PubMed ID: 33629142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
    Lee JW; Cho A; Yun M; Lee JD; Lyu CJ; Kang WJ
    Eur J Radiol; 2015 Dec; 84(12):2633-9. PubMed ID: 26462795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy.
    Cho HW; Lee ES; Lee JK; Eo JS; Kim S; Hong JH
    Ann Nucl Med; 2023 Jan; 37(1):44-51. PubMed ID: 36369325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [
    Bouron C; Mathie C; Seegers V; Morel O; Jézéquel P; Lasla H; Guillerminet C; Girault S; Lacombe M; Sher A; Lacoeuille F; Patsouris A; Testard A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic prediction by
    Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A
    Front Oncol; 2023; 13():1208531. PubMed ID: 37519817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonized pretreatment quantitative volume-based
    Kitajima K; Miyoshi Y; Sekine T; Takei H; Ito K; Suto A; Kaida H; Daisaki H; Yamakado K
    Hell J Nucl Med; 2020; 23(3):272-289. PubMed ID: 33367302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of semi-quantitative parameters of
    Wan B; Zhang S; Wang P; Deng P; Dai W
    Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
    Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.